Infinite Eagle Acquisition Corp.
IEAG CIK: 0002084396
Company Information
Industry Blank Checks
SIC Code 6770
Entity Type other
SEC Category Emerging growth company
State of Incorporation Cayman Islands
Business Address 955 FIFTH AVENUE, NEW YORK, NY, 10075
Mailing Address 955 FIFTH AVENUE, NEW YORK, NY, 10075
Phone 310-209-7280
Fiscal Year End 1231
EIN 981877055
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | January 26, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 23, 2026 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | January 23, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 21, 2026 | View on SEC |
| 4 Insider stock transaction report | January 20, 2026 | View on SEC |
| 8-K Current report of material events | January 20, 2026 | View on SEC |
| 424B4 Prospectus for IPO or offering | January 16, 2026 | View on SEC |
| 3 Initial insider ownership report | January 15, 2026 | View on SEC |
| 3 Initial insider ownership report | January 15, 2026 | View on SEC |
| 3 Initial insider ownership report | January 15, 2026 | View on SEC |
IPO Filings
S-1 November 20, 2025
- SPAC structure aiming to acquire or merge with a high-growth private company to take it public without traditional IPO hurdles
- Experienced leadership team with CEO John Carter (20+ years in finance) and CFO Sarah Lin (IPO management expertise)
Related Companies
Companies in the same industry (SIC: 6770)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.